NCT06327113View on ClinicalTrials.gov

Antibiotic Tumescent For Chronic Wounds

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 17, 2024

Primary Completion Date

May 25, 2027

Study Completion Date

May 25, 2028

Conditions
Non-healing Wound
Interventions
DRUG

CeFAZolin Injectable Solution

One gram Cefazolin reconstituted in 100 mL 0.9% Sodium Chloride (normal saline)

Trial Locations (1)

90095

RECRUITING

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER